勘误：肽和类肽在阿尔茨海默病血液诊断生物标志物中的应用最新进展。
Corrigendum: Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer's Disease in Blood.
作者信息
Guo Yuxin, Hu Zhiyuan, Wang Zihua
机构信息
CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, China.
University of Chinese Academy of Sciences, Beijing, China.
出版信息
Front Mol Neurosci. 2022 Feb 21;15:865110. doi: 10.3389/fnmol.2022.865110. eCollection 2022.
Abstract
[This corrects the article DOI: 10.3389/fnmol.2021.778955.].
摘要
[本文更正了文章的数字对象标识符：10.3389/fnmol.2021.778955。]
相似文献
1
Corrigendum: Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer's Disease in Blood.
Front Mol Neurosci. 2022 Feb 21;15:865110. doi: 10.3389/fnmol.2022.865110. eCollection 2022.
2
Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer's Disease in Blood.
Front Mol Neurosci. 2021 Dec 23;14:778955. doi: 10.3389/fnmol.2021.778955. eCollection 2021.
3
Corrigendum: Human Tau Expression Does Not Induce Mouse Retina Neurodegeneration, Suggesting Differential Toxicity of Tau in Brain vs. Retinal Neurons.
Front Mol Neurosci. 2018 Oct 24;11:390. doi: 10.3389/fnmol.2018.00390. eCollection 2018.
4
Corrigendum to "Alzheimer's Disease Dementia as the Diagnosis Best Supported by the Cerebrospinal Fluid Biomarkers: Difference in Cut-Off Levels from Thai Experience".
Int J Alzheimers Dis. 2017;2017:2647086. doi: 10.1155/2017/2647086. Epub 2017 Apr 2.
5
Corrigendum: The Importance of the Validation of M/EEG With Current Biomarkers in Alzheimer's Disease.
Front Hum Neurosci. 2019 Mar 6;13:81. doi: 10.3389/fnhum.2019.00081. eCollection 2019.
6
Corrigendum: A Brief Review of Paradigm Shifts in Prevention of Alzheimer's Disease: From Cognitive Reserve to Precision Medicine.
Front Psychiatry. 2019 Dec 17;10:900. doi: 10.3389/fpsyt.2019.00900. eCollection 2019.
7
Antibody-Mimetic Peptoid Nanosheet for Label-Free Serum-Based Diagnosis of Alzheimer's Disease.
Adv Mater. 2017 Aug;29(30). doi: 10.1002/adma.201700057. Epub 2017 Jun 12.
8
Label-free detection of Alzheimer's disease through the ADP3 peptoid recognizing the serum amyloid-beta42 peptide.
Chem Commun (Camb). 2015 Jan 14;51(4):718-21. doi: 10.1039/c4cc07037b.
9
Discovery of Neuroregenerative Peptoid from Amphibian Neuropeptide That Inhibits Amyloid-β Toxicity and Crosses Blood-Brain Barrier.
ACS Chem Neurosci. 2019 Mar 20;10(3):1355-1368. doi: 10.1021/acschemneuro.8b00427. Epub 2018 Nov 20.
10
Corrigendum to "Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer's disease" [Clin. Mass Spectrom. 14 (Part B) (2019) 74-82].
J Mass Spectrom Adv Clin Lab. 2022 Sep 28;26:35. doi: 10.1016/j.jmsacl.2022.08.002. eCollection 2022 Nov.
Zotero 插件